Though I like Albany Molecular, I'm surprised that there's earnings. Perhaps the Doom & Gloom about Allegra royalties was overblow. With another lab opening in India, perhaps we can expect increased revenues and earnings in the coming months and years. There's still uncertainty about Allegra patents, and Bristol Myers neuro compounds could become another royalty source. There's plenty of light at the end of this tunnel!